A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity

<jats:p>An adjuvant composed of saponin and a TLR4 agonist acts by enhancing lymph flow and antigen entry into lymph nodes.</jats:p>

Bibliographic Details
Main Authors:	Belcher, Angela, Irvine, Darrell
Other Authors:	Massachusetts Institute of Technology. Department of Biological Engineering
Format:	Article
Language:	English
Published:	American Association for the Advancement of Science (AAAS) 2023
Online Access:	https://hdl.handle.net/1721.1/147764

Internet

https://hdl.handle.net/1721.1/147764